Speech-Language Pathologists in Maryland - Medicare Status, Address, Contact

4261 Speech-Language Pathologists found. Showing 141 - 160

Erin Copus Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000

Kelsey Layla Onal, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000

Mrs. Micaela Huber, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000

Ashley Myers Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000

Paige Venanzi Shaffer, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000

Ms. Luann Abraham, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000

Mrs. Robin Failli, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1911 Lincoln Dr, Annapolis, MD 21401 Phone: 410-573-1064

Katherine Brown Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 130 Holiday Ct Ste 104, Annapolis, MD 21401 Phone: 410-871-2990    Fax: 443-293-8703

Kimberly Carey, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000

Mrs. Jennifer Mary Capo, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000

Laura Kristin Hulsey, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000

Karen Girken Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000

Mrs. Caitlin Mcnally Abbott, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000

Cristie Evoline Spivey Nolan Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000

Mrs. Carrie M Harris, M.S., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7101 Bay Front Dr, Annapolis, MD 21403 Phone: 410-268-9222

Erika Mathew, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000

Mrs. Jessica E Morris, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 412-222-5000

Ms. Jamie Lyn Coniglio, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000

Carolyn Dunsten Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000

Rhonda Lynn King, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000

News Archive

Nova Biomedical's subsidiary Sanvita CBGM to acquire assets of CCS Medical's subsidiary, Sanvita Inc

Nova Biomedical Corporation, a leading developer of whole blood analyzers, and CCS Medical, Inc. a leading direct-to-consumer provider of medical supplies, today announced that they have reached a definitive agreement under which Nova Biomedical's independent, wholly owned subsidiary, Sanvita CBGM, LLC, will acquire certain assets of Sanvita, Inc., a wholly-owned subsidiary of CCS Medical. Sanvita, Inc. is currently the exclusive distributor of Nova's "NovaMax" consumer blood glucose product line in the United States.

Shionogi receives FDA approval for Osphena to treat women with severe dyspareunia

The U.S. Food and Drug Administration today approved Osphena (ospemifene) to treat women experiencing moderate to severe dyspareunia (pain during sexual intercourse), a symptom of vulvar and vaginal atrophy due to menopause.

New study will examine why people live exceptionally long lives

Researchers at Washington University School of Medicine in St. Louis will head an ambitious study of people who live exceptionally long and healthy lives to identify the factors that account for their longevity.

XOMA reaches enrollment goal of 325 patients for Phase 2b clinical trial of XOMA 052

XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that it has reached the enrollment goal of 325 patients for its Phase 2b dose-ranging clinical trial of XOMA 052, and that it expects patient enrollment to close in July 2010, with top-line results available in the first quarter of 2011. XOMA 052 is a therapeutic antibody candidate that inhibits the pro-inflammatory cytokine interleukin-1 beta (IL-1 beta) which drives the inflammatory cause of Type 2 diabetes.

Read more Medical News

› Verified 1 days ago

• «
• 3
• 4
• 5
• 6
• 7
• 8(current)
• 9
• 10
• 11
• 12
• 13
• »